986 related articles for article (PubMed ID: 32383683)
1. Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach.
Alberts NM; Badawy SM; Hodges J; Estepp JH; Nwosu C; Khan H; Smeltzer MP; Homayouni R; Norell S; Klesges L; Porter JS; Hankins JS
JMIR Mhealth Uhealth; 2020 May; 8(5):e14884. PubMed ID: 32383683
[TBL] [Abstract][Full Text] [Related]
2. Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study.
Hankins JS; Shah N; DiMartino L; Brambilla D; Fernandez ME; Gibson RW; Gordeuk VR; Lottenberg R; Kutlar A; Melvin C; Simon J; Wun T; Treadwell M; Calhoun C; Baumann A; Potter MB; Klesges L; Bosworth H;
JMIR Res Protoc; 2020 Jul; 9(7):e16319. PubMed ID: 32442144
[TBL] [Abstract][Full Text] [Related]
3. Impact of the COVID-19 Pandemic on the Implementation of Mobile Health to Improve the Uptake of Hydroxyurea in Patients With Sickle Cell Disease: Mixed Methods Study.
Badawy SM; DiMartino L; Brambilla D; Klesges L; Baumann A; Burns E; DeMartino T; Jacobs S; Khan H; Nwosu C; Shah N; Hankins JS;
JMIR Form Res; 2022 Oct; 6(10):e41415. PubMed ID: 36240004
[TBL] [Abstract][Full Text] [Related]
4. Adherence to hydroxyurea, health-related quality of life domains and attitudes towards a smartphone app among Irish adolescents and young adults with sickle cell disease.
Fogarty H; Gaul A; Syed S; Aleksejenko N; Geoghegan R; Conroy H; Crampton E; Ngwenya N; Tuohy E; McMahon C
Ir J Med Sci; 2022 Apr; 191(2):809-816. PubMed ID: 33745105
[TBL] [Abstract][Full Text] [Related]
5. A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease.
Hankins JS; Brambilla D; Potter MB; Kutlar A; Gibson R; King AA; Baumann AA; Melvin C; Gordeuk VR; Hsu LL; Nwosu C; Porter JS; Alberts NM; Badawy SM; Simon J; Glassberg JA; Lottenberg R; DiMartino L; Jacobs S; Fernandez ME; Bosworth HB; Klesges LM; Shah N
Blood Adv; 2023 Dec; 7(23):7190-7201. PubMed ID: 37738155
[TBL] [Abstract][Full Text] [Related]
6. A Multidimensional Electronic Hydroxyurea Adherence Intervention for Children With Sickle Cell Disease: Single-Arm Before-After Study.
Creary S; Chisolm D; Stanek J; Hankins J; O'Brien SH
JMIR Mhealth Uhealth; 2019 Aug; 7(8):e13452. PubMed ID: 31397291
[TBL] [Abstract][Full Text] [Related]
7. A Medication Adherence App for Children With Sickle Cell Disease: Qualitative Study.
Curtis K; Lebedev A; Aguirre E; Lobitz S
JMIR Mhealth Uhealth; 2019 Jun; 7(6):e8130. PubMed ID: 31215518
[TBL] [Abstract][Full Text] [Related]
8. Technology Access and Smartphone App Preferences for Medication Adherence in Adolescents and Young Adults With Sickle Cell Disease.
Badawy SM; Thompson AA; Liem RI
Pediatr Blood Cancer; 2016 May; 63(5):848-52. PubMed ID: 26844685
[TBL] [Abstract][Full Text] [Related]
9. Mobile health intervention for youth with sickle cell disease: Impact on adherence, disease knowledge, and quality of life.
Anderson LM; Leonard S; Jonassaint J; Lunyera J; Bonner M; Shah N
Pediatr Blood Cancer; 2018 Aug; 65(8):e27081. PubMed ID: 29693797
[TBL] [Abstract][Full Text] [Related]
10. Study protocol for a randomized controlled trial to assess the feasibility of an open label intervention to improve hydroxyurea adherence in youth with sickle cell disease.
Smaldone A; Findley S; Bakken S; Matiz LA; Rosenthal SL; Jia H; Matos S; Manwani D; Green NS
Contemp Clin Trials; 2016 Jul; 49():134-42. PubMed ID: 27327779
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of iManage: A self-management app co-designed by adolescents with sickle cell disease.
Crosby LE; Ware RE; Goldstein A; Walton A; Joffe NE; Vogel C; Britto MT
Pediatr Blood Cancer; 2017 Jan; 64(1):139-145. PubMed ID: 27574031
[TBL] [Abstract][Full Text] [Related]
12. Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.
Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI
Health Qual Life Outcomes; 2017 Jul; 15(1):136. PubMed ID: 28679417
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease.
Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27896936
[TBL] [Abstract][Full Text] [Related]
14. Understanding patient-related barriers to hydroxyurea use among adolescent and adult patients with sickle cell disease in Mulago and Kiruddu hospitals, Uganda, a qualitative study.
Namaganda P; Nantume P; Mubiru KR; Twimukye A; Wiltshire CS
BMC Health Serv Res; 2024 May; 24(1):666. PubMed ID: 38802815
[TBL] [Abstract][Full Text] [Related]
15. Adherence to Hydroxyurea and Patients' Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional Study.
Madkhali MA; Abusageah F; Hakami F; Zogel B; Hakami KM; Alfaifi S; Alhazmi E; Zaalah S; Trabi S; Alhazmi AH; Mohrag M; Malhan H
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256385
[No Abstract] [Full Text] [Related]
16. Higher hydroxyurea adherence among young adults with sickle cell disease compared to children and adolescents.
Reddy PS; Cai SW; Barrera L; King K; Badawy SM
Ann Med; 2022 Dec; 54(1):683-693. PubMed ID: 35234095
[TBL] [Abstract][Full Text] [Related]
17. HABIT efficacy and sustainability trial, a multi-center randomized controlled trial to improve hydroxyurea adherence in youth with sickle cell disease: a study protocol.
Smaldone A; Manwani D; Aygun B; Smith-Whitley K; Jia H; Bruzzese JM; Findley S; Massei J; Green NS
BMC Pediatr; 2019 Oct; 19(1):354. PubMed ID: 31615480
[TBL] [Abstract][Full Text] [Related]
18. Preferences for Using a Mobile App in Sickle Cell Disease Self-management: Descriptive Qualitative Study.
Mayo-Gamble TL; Quasie-Woode D; Cunningham-Erves J; Rollins M; Schlundt D; Bonnet K; Murry VM
JMIR Form Res; 2021 Nov; 5(11):e28678. PubMed ID: 34851295
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the implementation of a multi-level mHealth study to improve hydroxyurea utilization in sickle cell disease.
Hankins JS; Potter MB; Fernandez ME; Melvin C; DiMartino L; Jacobs SR; Bosworth HB; King AA; Simon J; Glassberg JA; Kutlar A; Gordeuk VR; Shah N; Baumann AA; Klesges LM;
Front Health Serv; 2022; 2():1024541. PubMed ID: 36925803
[TBL] [Abstract][Full Text] [Related]
20. Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease.
Badawy SM; Thompson AA; Penedo FJ; Lai JS; Rychlik K; Liem RI
Eur J Haematol; 2017 Jun; 98(6):608-614. PubMed ID: 28306171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
